Search results
Results From The WOW.Com Content Network
Letrozole, sold under the brand name Femara among others, is an aromatase inhibitor medication that is used in the treatment of breast cancer for post-menopausal women. [ 1 ] It was patented in 1986 and approved for medical use in 1996. [ 4 ]
In 2022, the FDA reported that there have been six cases of idiopathic intracranial hypertension in 5 to 12-year-old children assigned female at birth taking puberty blockers. [77] Five who experienced the side effect were receiving treatment for precocious puberty and one who experienced the side effect was transgender and was receiving ...
Ramelteon, sold under the brand name Rozerem among others, is a melatonin agonist medication which is used in the treatment of insomnia. [3] [5] It is indicated specifically for the treatment of insomnia characterized by difficulties with sleep onset. [3] It reduces the time taken to fall asleep, but the degree of clinical benefit is small. [6]
Psychophysiological insomnia is anxiety-induced. Idiopathic insomnia generally begins in childhood and lasts for the rest of a person's life. It's suggested that idiopathic insomnia is a neurochemical problem in a part of the brain that controls the sleep-wake cycle, resulting in either under-active sleep signals or over-active wake signals.
Sleep problems in women can manifest at various stages of their life cycle, as supported by both subjective and objective data. [ further explanation needed ] Factors such as hormonal changes, aging, psycho-social aspects, physical and psychological conditions and the presence of sleeping disorders can disrupt women's sleep.
"As we get older, all of us should be thinking about how we want our future to look," says Dr. Jessica Caldwell, Ph.D., the director of the Women's Alzheimer's Movement Prevention Center at ...
Mayo Clinic is a nonprofit hospital system with campuses in Rochester, Minnesota; Scottsdale and Phoenix, Arizona; and Jacksonville, Florida. [22] [23] Mayo Clinic employs 76,000 people, including more than 7,300 physicians and clinical residents and over 66,000 allied health staff, as of 2022. [5]
Night terrors typically occur in children between the ages of three and twelve years, with a peak onset in children aged three and a half years old. [18] An estimated 1–6% of children experience night terrors. Children of both sexes and all ethnic backgrounds are affected equally. [18] In children younger than three and a half years old, the ...